Ieq Capital LLC Has $255,000 Holdings in DaVita Inc. (NYSE:DVA)

Ieq Capital LLC lessened its position in shares of DaVita Inc. (NYSE:DVA - Free Report) by 65.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,707 shares of the company's stock after selling 3,288 shares during the quarter. Ieq Capital LLC's holdings in DaVita were worth $255,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. Transcendent Capital Group LLC acquired a new stake in DaVita during the third quarter worth $25,000. Blue Trust Inc. boosted its position in shares of DaVita by 56.4% during the 3rd quarter. Blue Trust Inc. now owns 330 shares of the company's stock valued at $54,000 after acquiring an additional 119 shares in the last quarter. Quarry LP bought a new stake in DaVita in the third quarter valued at about $60,000. Venturi Wealth Management LLC raised its position in DaVita by 59.8% in the fourth quarter. Venturi Wealth Management LLC now owns 406 shares of the company's stock worth $61,000 after purchasing an additional 152 shares in the last quarter. Finally, Versant Capital Management Inc lifted its stake in DaVita by 58.7% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock worth $68,000 after purchasing an additional 169 shares during the period. 90.12% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

DVA has been the subject of several recent analyst reports. Barclays increased their price objective on DaVita from $164.00 to $169.00 and gave the stock an "equal weight" rating in a research note on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 target price on shares of DaVita in a research report on Friday, February 21st. Finally, Cowen restated a "hold" rating on shares of DaVita in a research report on Tuesday, February 18th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $166.33.

DaVita Stock Down 3.4 %

DVA stock traded down $5.06 during midday trading on Monday, hitting $142.82. The company's stock had a trading volume of 1,306,666 shares, compared to its average volume of 887,241. The company's fifty day moving average price is $160.45 and its 200 day moving average price is $158.18. DaVita Inc. has a twelve month low of $124.78 and a twelve month high of $179.60. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21. The stock has a market capitalization of $11.43 billion, a P/E ratio of 13.30, a PEG ratio of 1.07 and a beta of 0.94.

DaVita (NYSE:DVA - Get Free Report) last posted its quarterly earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, topping analysts' consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. As a group, equities research analysts predict that DaVita Inc. will post 10.76 EPS for the current year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.